Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Nov 5, 1997)

Reports
Other Events
Filing Date
Filed November 5, 1997
Period End
November 5, 1997
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed November 5, 1997. Cited figures are marked; the original filing is the authoritative source.

The Procter & Gamble Company filed this Form 8-K on November 5, 1997 under Item 9 (Sales of Equity Securities Pursuant to Regulations), disclosing a small private issuance of common stock.

On October 20, 1997, P&G sold 14,615 shares of its common stock to employees of its subsidiaries for approximately $1,029,232a in reliance on Regulation S, the SEC safe harbor for offshore offerings to non-U.S. persons. No underwriter or placement agent was used. The filing is immaterial from a valuation standpoint.

The proceeds of roughly $1.0 millionb are negligible relative to P&G's market capitalization and operating scale, and the implied price of about $70.43 per share is consistent with the company's trading range at the time. The transaction appears to be part of employee equity or compensation arrangements for overseas subsidiary staff rather than a capital-raising event. For investors, the main significance is administrative: the filing confirms that P&G is complying with its disclosure obligations for unregistered sales of equity securities.

It does not signal any change in strategy, financial position, dilution risk, or management outlook. Investors should treat this as routine corporate housekeeping.

Key Highlights

  1. P&G sold 14,615 shares of common stock on October 20, 1997, to employees of its subsidiaries.
  2. Total proceeds were approximately $1,029,232, implying about $70.43 per share.
  3. The sale was made in reliance on Regulation S, which covers offers and sales made outside the United States to non-U.S. persons.
  4. No underwriter or placement agent was involved, so the company received the full proceeds directly.
  5. The transaction is financially immaterial to P&G, which has a multi-billion-dollar market capitalization and revenue base.
  6. The filing was made under Item 9 of Form 8-K, which requires disclosure of certain unregistered equity sales.
  7. No change to business operations, guidance, or capital structure is indicated in the filing.

Frequently Asked Questions

  1. Does this stock sale materially dilute P&G shareholders?

    No. Roughly 14,615 shares is a negligible fraction of P&G's outstanding common stock, so any dilution is immaterial.

  2. Why did P&G sell shares under Regulation S?

    Regulation S provides an exemption from U.S. registration for offers and sales made outside the United States to non-U.S. persons. The filing indicates the buyers were employees of P&G subsidiaries, which suggests the sale was made to overseas staff, likely under an employee stock or compensation program.

  3. Does this filing indicate any change in P&G's financial condition?

    No. The filing discloses only a small equity sale and contains no financial statements, earnings information, or forward-looking statements that would affect valuation.

  4. Was an investment bank involved in this transaction?

    No. The filing explicitly states that no underwriter or placement agent was used, so the sale was made directly by the company.

  5. Should investors take action based on this filing?

    No. This is a routine disclosure of a small, immaterial sale of securities. It does not call for any change in investment decisions.